MicroRNA‑376a inhibits cell proliferation and invasion in osteosarcoma via directly targeting SATB1

Zhou,Guanghong; Jiang,Hao; Ma,Liping

doi:10.3892/mmr.2018.9344

MicroRNA‑376a inhibits cell proliferation and invasion in osteosarcoma via directly targeting SATB1

Authors:
- Guanghong Zhou
- Hao Jiang
- Liping Ma
View Affiliations

Affiliations: Department of Surgery, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China, Department of Nursing, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China
Published online on: August 1, 2018 https://doi.org/10.3892/mmr.2018.9344
Pages: 3521-3528

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Aberrantly expressed microRNAs (miRs) are implicated in the regulation of osteosarcoma (OS) onset and development. Therefore, key miRs in OS must be identified to develop promising and effective therapeutic targets for patients with OS. In the present study, reverse transcription‑quantitative polymerase chain reaction analysis revealed that miR‑376a‑3p expression was downregulated in OS tissues and cell lines. Additionally, decreased miR‑376a expression was associated with tumor size and lymph node infiltration. Restoration of miR‑376a expression reduced cell proliferation and invasion of OS. Furthermore, special AT‑rich sequence‑binding protein 1 (SATB1) was identified as a direct target gene of miR‑376a in OS cells. Furthermore, SATB1 was overexpressed in OS tissues and SATB1 overexpression was inversely correlated with the expression level of miR‑376a. In addition, ectopic SATB1 expression counteracted the inhibitory effects of miR‑376a overexpression on the proliferation and invasion of OS cells. All these results identified that reduced miR‑376a expression may be implicated in the mechanism underlying OS progression, suggesting that the miR‑376a/SATB1 axis may be a promising novel target for potential therapeutic methods for the effective treatment of patients with OS.

View Figures

View References

1	Maximov VV and Aqeilan RI: Genetic factors conferring metastasis in osteosarcoma. Future Oncol. 12:1623–1644. 2016. View Article : Google Scholar : PubMed/NCBI
2	Mirabello L, Troisi RJ and Savage SA: Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the surveillance, epidemiology, and end results program. Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
3	Ritter J and Bielack SS: Osteosarcoma. Ann Oncol. 21 Suppl 7:vii320–vii325. 2010. View Article : Google Scholar : PubMed/NCBI
4	Liebner DA: The indications and efficacy of conventional chemotherapy in primary and recurrent sarcoma. J Surg Oncol. 111:622–631. 2015. View Article : Google Scholar : PubMed/NCBI
5	Fagioli F, Aglietta M, Tienghi A, Ferrari S, del Prever Brach A, Vassallo E, Palmero A, Biasin E, Bacci G, Picci P and Madon E: High-dose chemotherapy in the treatment of relapsed osteosarcoma: An Italian sarcoma group study. J Clin Oncol. 20:2150–2156. 2002. View Article : Google Scholar : PubMed/NCBI
6	Bacci G, Balladelli A, Palmerini E, Alberghini M, Pollastri P, Galletti S, Mercuri M and Picci P: Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients: The Rizzoli Institute experience. J Pediatr Hematol Oncol. 30:908–912. 2008. View Article : Google Scholar : PubMed/NCBI
7	Dong J, Liu Y, Liao W, Liu R, Shi P and Wang L: miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma. J Bone Oncol. 5:74–79. 2016. View Article : Google Scholar : PubMed/NCBI
8	Berindan-Neagoe I and Calin GA: Molecular pathways: microRNAs, cancer cells, and microenvironment. Clin Cancer Res. 20:6247–6253. 2014. View Article : Google Scholar : PubMed/NCBI
9	Ambros V: The functions of animal microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
10	Sassen S, Miska EA and Caldas C: MicroRNA: Implications for cancer. Virchows Arch. 452:1–10. 2008. View Article : Google Scholar : PubMed/NCBI
11	Cai W, Jiang H, Yu Y, Xu Y, Zuo W, Wang S and Su Z: miR-367 regulation of DOC-2/DAB2 interactive protein promotes proliferation, migration and invasion of osteosarcoma cells. Biomed Pharmacother. 95:120–128. 2017. View Article : Google Scholar : PubMed/NCBI
12	Fu F, Wan X, Wang D, Kong Z, Zhang Y, Huang W, Wang C, Wu H and Li Y: MicroRNA-19a acts as a prognostic marker and promotes prostate cancer progression via inhibiting VPS37A expression. Oncotarget. 9:1931–1943. 2018. View Article : Google Scholar : PubMed/NCBI
13	Yang Y, Jiang Z, Ma N, Wang B, Liu J, Zhang L and Gu L: MicroRNA-223 Targeting STIM1 inhibits the biological behavior of breast cancer. Cell Physiol Biochem. 45:856–866. 2018. View Article : Google Scholar : PubMed/NCBI
14	Du B, Wu D, Yang X, Wang T, Shi X, Lv Y, Zhou Z, Liu Q and Zhang W: The expression and significance of microRNA in different stages of colorectal cancer. Medicine (Baltimore). 97:e96352018. View Article : Google Scholar : PubMed/NCBI
15	Macfarlane LA and Murphy PR: MicroRNA: Biogenesis, function and role in cancer. Curr Genomics. 11:537–561. 2010. View Article : Google Scholar : PubMed/NCBI
16	Li Y, Wu Y, Sun Z, Wang R and Ma D: MicroRNA376a inhibits cell proliferation and invasion in glioblastoma multiforme by directly targeting specificity protein 1. Mol Med Rep. 17:1583–1590. 2018.PubMed/NCBI
17	Zheng Y, Yin L, Chen H, Yang S, Pan C, Lu S, Miao M and Jiao B: miR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma. FEBS Lett. 586:2396–2403. 2012. View Article : Google Scholar : PubMed/NCBI
18	Formosa A, Markert EK, Lena AM, Italiano D, Finazzi-Agro' E, Levine AJ, Bernardini S, Garabadgiu AV, Melino G and Candi E: MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells. Oncogene. 33:5173–5182. 2014. View Article : Google Scholar : PubMed/NCBI
19	Wang Y, Cong W, Wu G, Ju X, Li Z, Duan X, Wang X and Gao H: MiR-376a suppresses the proliferation and invasion of non-small-cell lung cancer by targeting c-Myc. Cell Biol Int. 42:25–33. 2018. View Article : Google Scholar : PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
21	Zhang H, Qu S, Li S, Wang Y, Li Y, Wang Y, Wang Z and Li R: Silencing SATB1 inhibits proliferation of human osteosarcoma U2OS cells. Mol Cell Biochem. 378:39–45. 2013. View Article : Google Scholar : PubMed/NCBI
22	Zhang H, Su X, Guo L, Zhong L, Li W, Yue Z, Wang X, Mu Y, Li X, Li R and Wang Z: Silencing SATB1 inhibits the malignant phenotype and increases sensitivity of human osteosarcoma U2OS cells to arsenic trioxide. Int J Med Sci. 11:1262–1269. 2014. View Article : Google Scholar : PubMed/NCBI
23	Li X, Sun X, Wu J and Li Z: MicroRNA-613 suppresses proliferation, migration and invasion of osteosarcoma by targeting c-MET. Am J Cancer Res. 6:2869–2879. 2016.PubMed/NCBI
24	Qu Q, Chu X and Wang P: MicroRNA-195-5p suppresses osteosarcoma cell proliferation and invasion by suppressing naked cuticle homolog 1. Cell Biol Int. 41:287–295. 2017. View Article : Google Scholar : PubMed/NCBI
25	Ren X, Shen Y, Zheng S, Liu J and Jiang X: miR-21 predicts poor prognosis in patients with osteosarcoma. Br J Biomed Sci. 73:158–162. 2016. View Article : Google Scholar : PubMed/NCBI
26	Huang Q, Wang C, Hou Z, Wang G, Lv J, Wang H, Yang J, Zhang Z and Zhang H: Serum microRNA-376 family as diagnostic and prognostic markers in human gliomas. Cancer Biomark. 19:137–144. 2017. View Article : Google Scholar : PubMed/NCBI
27	Mo ZH, Wu XD, Li S, Fei BY and Zhang B: Expression and clinical significance of microRNA-376a in colorectal cancer. Asian Pac J Cancer Prev. 15:9523–9527. 2014. View Article : Google Scholar : PubMed/NCBI
28	Meng X, Joosse SA, Muller V, Trillsch F, Milde-Langosch K, Mahner S, Geffken M, Pantel K and Schwarzenbach H: Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients. Br J Cancer. 113:1358–1366. 2015. View Article : Google Scholar : PubMed/NCBI
29	Yang L, Wei QM, Zhang XW, Sheng Q and Yan XT: MiR-376a promotion of proliferation and metastases in ovarian cancer: Potential role as a biomarker. Life Sci. 173:62–67. 2017. View Article : Google Scholar : PubMed/NCBI
30	Zheng Y, Chen H, Yin M, Ye X, Chen G, Zhou X, Yin L, Zhang C and Ding B: MiR-376a and histone deacetylation 9 form a regulatory circuitry in hepatocellular carcinoma. Cell Physiol Biochem. 35:729–739. 2015. View Article : Google Scholar : PubMed/NCBI
31	Tu W, Luo M, Wang Z, Yan W, Xia Y, Deng H, He J, Han P and Tian D: Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer. Liver Int. 32:1064–1078. 2012. View Article : Google Scholar : PubMed/NCBI
32	Xiang J, Zhou L, Li S, Xi X, Zhang J, Wang Y, Yang Y, Liu X and Wan X: AT-rich sequence binding protein 1: Contribution to tumor progression and metastasis of human ovarian carcinoma. Oncol Lett. 3:865–870. 2012.PubMed/NCBI
33	Lu X, Cheng C, Zhu S, Yang Y, Zheng L, Wang G, Shu X, Wu K, Liu K and Tong Q: SATB1 is an independent prognostic marker for gastric cancer in a Chinese population. Oncol Rep. 24:981–987. 2010.PubMed/NCBI
34	Mao L, Yang C, Wang J, Li W, Wen R, Chen J and Zheng J: SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion. J Transl Med. 11:1112013. View Article : Google Scholar : PubMed/NCBI
35	Baba H, Ishikawa T, Mogushi K, Ishiguro M, Uetake H, Tanaka H and Sugihara K: Identification of SATB1 as a specific biomarker for lymph node metastasis in colorectal cancer. Anticancer Res. 36:4069–4076. 2016.PubMed/NCBI